VBL Therapeutics Announces That S-4 Registration Statement For Proposed Merger With Notable Labs Is Declared Effective By SEC
Merger with Notable expected to close in mid-October, subject to shareholder approval
Special shareholder meeting scheduled for October 12, 2023
MODI'IN, Israel and NEW YORK, Sept. 06, 2023 (GLOBE NEWSWIRE)